SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol

SGLT2 (Sodium-glucose Cotransporter-2) inhibitors are newer glucose-lowering drugs with many cardiovascular benefits that are not fully understood yet. Endothelial integrity plays a key role in cardiovascular homeostasis. 25-hydroxycholesterol (25-OHC), which is a proatherogenic stimuli that impairs...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlos, Agnieszka, Broncel, Marlena, Woźniak, Ewelina, Markiewicz, Łukasz, Piastowska-Ciesielska, Agnieszka, Gorzelak-Pabiś, Paulina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921803/
https://www.ncbi.nlm.nih.gov/pubmed/36770777
http://dx.doi.org/10.3390/molecules28031112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921803/
https://www.ncbi.nlm.nih.gov/pubmed/36770777
http://dx.doi.org/10.3390/molecules28031112

Ejemplares similares